Caredx IncCDNA
Price$66.23Intrinsic value$97.7748% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $458.1M+37.2% YoYTTM through 30 Jun 2026
Net Income $111M+111.3% YoYTTM through 30 Jun 2026
Free Cash Flow $85.3MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin26.8%
Operating Margin23.6%
Net Margin24.2%

Returns

26.1%ROE
20.8%ROA
213.6%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio4.58x
Net Debt-$373.6Mnet cash position
Cash & Equivalents$373.6M

Quality Metrics

Altman Z-Score17.28
Piotroski F-Score6 / 9
FCF Margin18.6%
Rule of 4026.7
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $379.8M
Diluted EPS$2.08TTM
'19'20'21'22'23'24'25
FY2025: $-0.40

Dividend

No dividend

Capital Allocation

R&D Spend$79.9M
Capex Intensity1.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.